| 000 | 01597 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515004832.0 | ||
| 264 | 0 | _c20060412 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.wnl.0000183284.92920.f2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuerger, K | |
| 245 | 0 | 0 |
_aPhosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study. _h[electronic resource] |
| 260 |
_bNeurology _cNov 2005 |
||
| 300 |
_a1502-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aCognition Disorders _xcerebrospinal fluid |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEpitopes _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_atau Proteins _xcerebrospinal fluid |
| 700 | 1 | _aEwers, M | |
| 700 | 1 | _aAndreasen, N | |
| 700 | 1 | _aZinkowski, R | |
| 700 | 1 | _aIshiguro, K | |
| 700 | 1 | _aVanmechelen, E | |
| 700 | 1 | _aTeipel, S J | |
| 700 | 1 | _aGraz, C | |
| 700 | 1 | _aBlennow, K | |
| 700 | 1 | _aHampel, H | |
| 773 | 0 |
_tNeurology _gvol. 65 _gno. 9 _gp. 1502-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000183284.92920.f2 _zAvailable from publisher's website |
| 999 |
_c15900864 _d15900864 |
||